Company: PAII-WT
Filing Date: 2025-05-29
Form Type: DRS
Source: 0001213900-25-049013
Chunk: 157

Company: Pyrophyte Acquisition Corp. II
Filing Date: 2025-05-29
Form: DRS
Chunk 157
---
                                                       |     | $      |   840,000 |     | 56.0%      |
| Directors’ and officers’ liability insurance                                                      |     | $      |   350,000 |     | 23.3%      |
| Total                                                                                             |     | $      | 1,500,000 |     | 100.0%     |

____________ (1)Includes amounts payable to public shareholders who properly redeem their shares in connection with our successful completion of our initial business combination. (2)A portion of the offering expenses have been paid from the proceeds of loans from our sponsor of up to $300,000 as described in this prospectus. These loans will be repaid upon completion of this offering out of the $925,000 of offering proceeds that has been allocated for the payment of offering expenses other than underwriting commissions. In the event that offering expenses are less than set forth in this table, any such amounts will be used for post -closingworking capital expenses. (3) The underwriters have agreed to defer underwriting commissions equal to up to 4.5% of the gross proceeds of the units sold in the base offering, or $7,875,000 in the aggregate. In addition, if the underwriters’ over -allotmentoption is exercised, $0.60 per unit sold pursuant to the over -allotmentoption, or up to an additional $1,575,000, will be deferred. Upon completion of our initial business combination, $7,875,000 in the aggregate, (or $9,450,000 if the over -allotmentoption is exercised in full) which constitutes the deferred underwriting commissions, will be paid to UBS from the remaining cash held in the Company’s trust account at the closing of the initial business combination. The remaining funds will be released to us and can be used to pay all

| 110 |

| Use of proceeds |

or a portion of the purchase price of the business or businesses with which our initial business combination occurs or for general corporate purposes, including payment of principal or interest on indebtedness incurred in connection with our initial business combination, to fund the purchases of other companies, or for working capital. The underwriters will not be entitled to any interest accrued on the deferred underwriting discounts and commissions. (4)These expenses are estimates only. Our actual expenditures for some or all of these items may differ from the estimates set forth herein. For example, we may incur greater legal and